These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 2973600

  • 1. [Ceftazidime for the treatment of infections in neutropenic children].
    Leverger G, Arlet G, Bancillon A, Schaison G.
    Presse Med; 1988 Oct 26; 17(37):1974-6. PubMed ID: 2973600
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
    Marie JP, Pico JL, Chiche D, Fitoussi F, Delmer A, Baume D, Rio B, Ajchenbaum F, Richet H, Tancrède C.
    Presse Med; 1988 Oct 26; 17(37):1968-70. PubMed ID: 2973598
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].
    Schaison G, Leverger G, Pappo M, Chiche D.
    Pathol Biol (Paris); 1990 Jun 26; 38(5 ( Pt 2)):557-60. PubMed ID: 2200996
    [Abstract] [Full Text] [Related]

  • 6. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP, Bru JP, Michallet M, Corron B, Fauconnier J.
    Presse Med; 1988 Oct 26; 17(37):1964-7. PubMed ID: 2973597
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey.
    Agaoglu L, Devecioglu O, Anak S, Karakas Z, Yalman N, Biner B, Eryilmaz E, Goksan B, Unuvar A, Agirbasli H, Can M, Bilgen H, Gedikoglu G.
    J Chemother; 2001 Jun 26; 13(3):281-7. PubMed ID: 11450887
    [Abstract] [Full Text] [Related]

  • 10. Randomized trial comparing netilmicin plus imipenem-cilastatin versus netilmicin plus ceftazidime as empiric therapy for febrile neutropenic bone marrow transplant recipients.
    Laszlo D, Bacci S, Bosi A, Fanci R, Guidi S, Saccardi R, Vannucchi AM, Rossi Ferrini P.
    J Chemother; 1997 Apr 26; 9(2):95-101. PubMed ID: 9176746
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ, Fainstein V, Bodey GP, Rolston K, Elting L, Kantarjian H, Cabanillas F, McCredie KB.
    Am J Med; 1988 Mar 26; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [Abstract] [Full Text] [Related]

  • 15. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L, Wells H, Lange BJ.
    Pediatr Infect Dis J; 1988 Mar 26; 7(3):165-70. PubMed ID: 3282214
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.
    Mustafa MM, Carlson L, Tkaczewski I, McCracken GH, Buchanan GR.
    Pediatr Infect Dis J; 2001 Mar 26; 20(3):362-9. PubMed ID: 11303851
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.